scispace - formally typeset
R

Reinhard Büttner

Researcher at University Hospital Bonn

Publications -  55
Citations -  2727

Reinhard Büttner is an academic researcher from University Hospital Bonn. The author has contributed to research in topics: Prostate cancer & Carcinoma. The author has an hindex of 18, co-authored 55 publications receiving 2532 citations. Previous affiliations of Reinhard Büttner include RWTH Aachen University & University Medical Center Freiburg.

Papers
More filters
Journal ArticleDOI

Integrated THz technology for label-free genetic diagnostics

TL;DR: In this paper, a promising approach for the label-free analysis of DNA molecules using direct probing of the binding state of DNA with electromagnetic waves at THz frequencies is reported, which provides a drastically enhanced sensitivity enabling analysis down to femtomol levels.
Journal ArticleDOI

Label-free probing of the binding state of DNA by time-domain terahertz sensing

TL;DR: Time-resolved terahertz transmission analysis of polynucleotides demonstrates a strong dependence of the complex refractive index on the binding state (hybridized/denatured) of deoxyribonucleic acid (DNA) molecules, which can be inferred by monitoring THz transients and hence identify polyn nucleotides by detecting the binding of unknown polyn DNA sequences to known probe molecules.
Journal ArticleDOI

Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD).

TL;DR: This is the first study that reports the long-term outcome of ARPKD patients with defined PK HD1 mutations, indicating that PKHD1 mutation screening is a powerful diagnostic tool in patients suspected with AR PKD.
Journal ArticleDOI

Global levels of histone modifications predict prostate cancer recurrence

TL;DR: This study was performed to evaluate histone lysine and histone acetyl modifications in prostate tissue to evaluate their predictors of cancer recurrence in various tumor entities.
Journal ArticleDOI

CpG Island Hypermethylation in Cell-Free Serum DNA Identifies Patients With Localized Prostate Cancer

TL;DR: The aim was to analyze the diagnostic and prognostic possibilities of multigene methylation analysis in cell‐free serum DNA of prostate cancer (PCA) patients.